Clark Eliana - Insider Non-Derivative Transactions at Intellia Therapeutics, Inc. (NTLA) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jul 1, 2024, Clark Eliana's relationship to Intellia Therapeutics, Inc. (NTLA) is Officer (EVP, Chief Technical Officer), and currently has 71,470 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other NTLA insiders.

Data Source: SEC.
Clark Eliana - Insider Non-Derivative Transactions of NTLA Common Stock
Clark Eliana - Insider Non-Derivative Transactions at NTLA
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jul 2, 2024 Sell -- (Common Stock) 405 22.93 71470
Mar 5, 2024 Sell -- (Common Stock) 605 32.99 71470
Mar 2, 2024 Acquisition -- (Common Stock) 31230 0 72075
Jan 4, 2024 Sell -- (Common Stock) 4301 29.46 40845
Jan 4, 2024 Sell -- (Common Stock) 307 30.12 45146
Jul 4, 2023 Sell -- (Common Stock) 360 40.51 45146
Jun 21, 2023 Sell -- (Common Stock) 5000 45 45146
Jun 21, 2023 M -- (Common Stock) 5000 12.27 50146
Mar 2, 2023 Acquisition -- (Common Stock) 24539 0 39012
Mar 2, 2023 Acquisition -- (Common Stock) 6134 0 45146
Jan 5, 2023 Sell -- (Common Stock) 1692 37.21 14473
Jan 4, 2023 Sell -- (Common Stock) 231 34.48 16165
Jul 2, 2022 Sell -- (Common Stock) 105 51.74 16165